Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» MannKind announces FDA acknowledgement of NDA resubmission for Afrezza
MannKind announces FDA acknowledgement of NDA resubmission for Afrezza
MannKind announces FDA acknowledgement of NDA resubmission for Afrezza
Submitted by
admin
on October 30, 2013 - 9:45am
Source:
Yahoo/Fly on the Wall
News Tags:
diabetes
inhaled insulin
MannKind
FDA
Afrezza
Headline:
MannKind announces FDA acknowledgement of NDA resubmission for Afrezza
Do Not Allow Advertisers to Use My Personal information
